Navigation Links
NxStage® Names Michael Miller, Jr. President, International
Date:4/27/2011

LAWRENCE, Mass., April 27, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Michael Miller, Jr., former Senior Vice President and General Manager of the Cardiac Care Business at Philips Healthcare, has joined the NxStage senior management team in the newly-created position of President, International.

Miller will be responsible for advancing the Company's international growth plans in the European Union (EU), the Middle East, and Asia-Pacific. "I believe NxStage has a tremendous opportunity to expand patient access to its life-changing products across the globe," said Miller. "This is a remarkable company that I believe has the potential to truly transform renal care on an even broader scale.  I am excited to join NxStage and to bring my experience in international medical device sales and business development to its important mission."

During ten years at Philips, Miller held leadership roles in marketing and general management for a variety of global businesses.  In his most recent role as Senior Vice President and General Manager of the Philips Cardiac Care Business he led worldwide expansion efforts for four medical device businesses across new and emerging markets. Prior to Philips, Miller was Director and Vice President of U.S. Sales for Advanced Sterilization Products, a division of Johnson & Johnson Medical, Inc., as well as Director of International and New Business Development- Worldwide.  He also held various positions with Hewlett Packard Medical Products Group that included responsibilities for domestic and international product marketing in several product areas.  Miller holds an MBA from Harvard Graduate School of Business Administration and a BA in economics from Yale University.

"Mike's strong track record in global sales over three decades for some of the premier leaders in our industry speaks for itself," said Jeffrey Burbank, Chief Executive Officer of NxStage Medical, Inc. "NxStage is very pleased that such a proven leader shares our vision and excitement to make a life-changing difference in renal care for patients with ESRD.  I believe Mike's skills and experience will be invaluable to us as we advance our international expansion strategy."

About NxStage

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. The forward-looking statements in this release include statements as to NxStage's ability to expand patient access to its products worldwide and NxStage's ability to transform renal care worldwide. Results may differ materially from those indicated by these forward-looking statements as a result of various important factors including customer demand for our products in the European Union (EU), the Middle East and Asia-Pacific and other factors  that are discussed in NxStage's Annual Report on Form 10-K for the year ended December 31, 2010 filed with the SEC. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Media Contact:
Kristen Sheppard, Esq.
Vice President, Investor Relations
NxStage Medical, Inc.
ir@nxstage.com
978-332-5923


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NxStage® to Report First Quarter Fiscal 2011 Financial Results
2. New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period
3. In Celebration of the 31st Annual Dialysis Conference, NxStage® Announces Over 5,000 Patients Using the System One™ for Home Hemodialysis
4. NxStage® Reports Fourth Quarter and Full-Year 2010 Financial Results; Revenue Growth Exceeds Company Guidance
5. NxStage® to Report Fourth Quarter and Full Year 2010 Financial Results
6. NxStage® Appoints Nancy J. Ham to Its Board of Directors and Announces Resignation of Board Member Jonathan T. Silverstein
7. First NxStage® Home Hemodialysis Patients Celebrate Seven-Year Anniversary
8. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
9. Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance
10. BridgePoint Medical Names Industry Veteran as Chief Executive Officer
11. Survey Sampling International Names Chris DeAngelis to Head New SSI Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... -- According to market research "Global Magnetic ... Demand Forecast to 2022 - Industry Insights by Architecture ... High Field, Low to Mid Field, and Ultra High ... Vascular, Breast, Pelvic and Abdomen, Cardiac, and Other)" P&S ... was valued at $5,351.7 million in 2015, and it ...
(Date:5/3/2016)... , May 3, 2016 ... Research Report provides a basic overview of the ... post which the surgical mesh report explores into ... Complete report on Surgical Mesh market ... and 98 tables and figures is available at ...
(Date:5/2/2016)... 2016  Deerfield announced today it led the ... Inc. Graybug Vision is an early stage pharmaceutical ... care for ocular diseases including wet age-related macular ... first developed at Johns Hopkins University and has ... Graybug Vision is developing ophthalmology products ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... May 03, 2016 , ... Sandbox, one of ... to serve in the newly created position of executive vice president, chief creative ... efforts in the Chicago and LA offices. He reports to Nancy Finigan, president ...
(Date:5/3/2016)... ... May 03, 2016 , ... University of the ... the launch of its Associates and Bachelor's degrees in Health Studies. Leading figures ... University, Dr. Torsten N. Wiesel; Chairman and CEO of Fortune 500® company Henry ...
(Date:5/3/2016)... Toledo, OH (PRWEB) , ... May 03, 2016 , ... ... remain a leading cause of death across the United States and account for one ... physical and mental impairments or are permanently disabled. HCR ManorCare is launching a video ...
(Date:5/3/2016)... ... May 03, 2016 , ... For the sixth consecutive year, ... Technology (ICT) companies in the annual Branham300 listing. For 23 years, the Branhan300 ... ranked by revenue. , “We are honored to be on the Branham300 ...
(Date:5/3/2016)... ... May 03, 2016 , ... Branches, Inc. is proud to ... Climb children and youth programs in South Miami. Macy’s is a wonderful community partner ... Grow Program provides afterschool tutoring, mentoring, enrichment and academic support to elementary students 5 ...
Breaking Medicine News(10 mins):